Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05253560 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prodromal Parkinsonian Features in GBA1 Mutation Carriers

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 16, 2024 to Jan 16, 2030 Completion date: Dec 31, 2025 to Dec 31, 2030v4 Show 1 more changeShow less
    • Completion date: Dec 31, 2025 to Dec 31, 2030
  2. Re-verified, no change to tracked fieldsv3
  3. Primary completion date: May 16, 2022 to Jan 16, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Objective of the trial. To define a sub-population which is at increased risk of developing Parkinson, beyond the fact of carrying Gaucher; in this sub-population the investigators shall conduct a comprehensive evaluation that includes a variety of non-invasive tests, whose purpose is to evaluate the state of the pre- Parkinson's disease signs, signs which can appear, even twenty years before the appearance of the disease, and also to compare them to a group of diagnosed Gaucher patients and a group of healthy people who are not carriers of Gaucher disease. A group of those carriers will be available for trial or for treatment, if there will be a medicine for the prevention of the development of Parkinson, obtainable.
Trial Details
NCT Number NCT05253560
Lead Sponsor Shaare Zedek Medical Center
Conditions Gaucher Disease, Type 1, Healthy
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov